Robert Guirguis, DO
Pain Medicine · Tampa, FLNPI 1134170038
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $25,889 of the $29,711 with a category attached, or 87.1%. 55 manufacturers reported payments, led by Medtronic at 24.5% of the total. Among pain medicine clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,098 payments — averaging $27.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$7K
- Boston Scientific$2K
- Abbott$2K
- AbbVie$2K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
- Curonix LLC$2K
- plus $13K from 49 others
Across 28 payments — averaging $30,903 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Seikagaku Corporation$864K
- Scilex Pharmaceuticals Inc.$1K
What the payments were for
- Travel & lodging$3,40211%
- Food & beverage$25,88987%
- Education$4031%
- Entertainment$160%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS ADAPTIVESTIM$3,860
- Intracept$2,558
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$1,100
- WaveWriter Alpha Prime 16$1,096
- INCEPTIV$715
- PROCLAIM$653
- Senza$484
- Proclaim Family of SCS IPGs$271
- NURTEC ODT$233
- QUVIVIQ$222
- Nexwave$180
- ETERNA$165
- ZTLido$152
- Senza Spinal Cord Stimulation System$150
- SPRINT PNS System$130
- Dayvigo$126
- UBRELVY$121
- ZEPOSIA$121
- BELBUCA$114
- mild Device Kit$104
How this compares
$29,711 in reported general payments places this provider in the 90th percentile of 596 pain medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 238 | $149,042 |
| Ergotamine-CaffeineErgotamine Tartrate/Caffeine | 57 | $83,117 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,831 | $66,747 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 2,116 | $66,396 |
| Oxycodone Hcl | 2,941 | $62,472 |
| BelbucaBuprenorphine Hcl | 68 | $55,793 |
| MovantikNaloxegol Oxalate | 101 | $52,447 |
| RelistorMethylnaltrexone Bromide | 16 | $45,058 |
| Morphine Sulfate ErMorphine Sulfate | 1,330 | $34,084 |
| LinzessLinaclotide | 53 | $32,905 |
| Naproxen | 124 | $26,660 |
| QuliptaAtogepant | 21 | $22,466 |
| Sumatriptan | 77 | $21,718 |
| Celecoxib | 628 | $21,484 |
| Hydromorphone Hcl | 753 | $20,318 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca, Nucynta | $1,523 | $218,885320 claims |
| AbbVieLinzess, Qulipta | $1,988 | $55,37274 claims |
| Redhill Biopharma Inc.Movantik | $267 | $52,447101 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $1,650 | $45,05816 claims |
| Hikma Pharmaceuticals USAMorphine Sulfate, Buprenorphine, Buprenorphine-Naloxone | $21 | $25,095440 claims |
| Idorsia Pharmaceuticals US IncQuviviq | $598 | $11,95924 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $1,126 | $9,89022 claims |
| Arbor Pharmaceuticals, Inc.Horizant | $190 | $9,24418 claims |
| Eisai Inc.Dayvigo | $378 | $5,21516 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 596 pain medicine providers in Florida.
Other pain medicine in Tampa
- Rodolfo GariTampa$120K
- Edward Podgorski IiiTampa$55K
- Arun KalavaTampa$36K
- Mauricio OrbegozoTampa$31K
- Abraham RiveraTampa$27K
- Jorge LealTampa$18K
- Jeffrey GudinMiami$356K
- Joseph PergolizziNaples$333K
- Ramon Cuevas-TrisanRiviera Beach$220K
- Navdeep JassalLakeland$163K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.